Avid Bioservices, Inc. (CDMO)

Market Cap	796.34M
Revenue (ttm)	150.45M
Net Income (ttm)	-152.05M
Shares Out	63.96M
EPS (ttm)	-2.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,888,728
Open	12.45
Previous Close	12.46
Day's Range	12.42 - 12.47
52-Week Range	5.90 - 12.48
Beta	1.41
Analysts	Hold
Price Target	12.25 (-1.61%)
Earnings Date	Dec 10, 2024

About CDMO

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line developme...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 371
• Stock Exchange: NASDAQ
• Ticker Symbol: CDMO
• Website: https://www.avidbio.com

Analyst Forecast

According to 3 analysts, the average rating for CDMO stock is "Hold." The 12-month stock price forecast is $12.25, which is a decrease of -1.61% from the latest price.

Price Target

$12.25

(-1.61% downside)

Analyst Consensus: Hold